Elazar Rabbani - Enzo Biochem Chairman
| ENZDelisted Stock | USD 0.54 0.01 1.89% |
Chairman
Dr. Elazar Rabbani, Ph.D. is the Chairman of the Board, Chief Executive Officer, Secretary of the Company. He has authored numerous scientific publications in the field of molecular biology, in particular, nucleic acid labeling and detection. He is also the lead inventor of many of the Companys pioneering patents covering a wide range of technologies and products since 2021.
| Age | 81 |
| Tenure | 5 years |
| Professional Marks | Ph.D |
| Phone | 631 755 5500 |
| Web | https://www.enzo.com |
Enzo Biochem Management Efficiency
The company has Return on Asset of (0.0746) % which means that on every $100 spent on assets, it lost $0.0746. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1295) %, meaning that it generated no profit with money invested by stockholders. Enzo Biochem's management efficiency ratios could be used to measure how well Enzo Biochem manages its routine affairs as well as how well it operates its assets and liabilities.Enzo Biochem has 3.51 M in debt with debt to equity (D/E) ratio of 0.38, which is OK given its current industry classification. Enzo Biochem has a current ratio of 2.17, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. That said, strategic use of leverage may enable Enzo to fund expansion initiatives and generate superior returns.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is headquartered in Farmingdale, New York. Enzo Biochem operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 465 people. Enzo Biochem (ENZ) is traded on New York Stock Exchange in USA and employs 125 people. Management Performance
| Return On Equity | -0.13 | |||
| Return On Asset | -0.0746 |
Enzo Biochem Leadership Team
Elected by the shareholders, the Enzo Biochem's board of directors comprises two types of representatives: Enzo Biochem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enzo. The board's role is to monitor Enzo Biochem's management team and ensure that shareholders' interests are well served. Enzo Biochem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enzo Biochem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dieter MD, Chief Labs | ||
| Hamid Erfanian, Chief Executive Officer, Director | ||
| Barry Weiner, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Director | ||
| Mary Tagliaferri, Lead Independent Director | ||
| Dov Perlysky, Lead Independent Director | ||
| Bruce Dey, Vice President - Sales and Marketing of Enzo Clinical Labs | ||
| Ian Walters, Independent Director | ||
| Matthew Kupferberg, General Secretary | ||
| David Bench, Chief Financial Officer, Senior Vice President, Treasurer, Corporate Secretary | ||
| Peter Clemens, Director | ||
| Brian Fisher, General Secretary | ||
| Bruce Hanna, Independent Director | ||
| Patricia CPA, Interim Officer | ||
| Rebecca Fischer, Independent Director | ||
| Elazar Rabbani, Chairman of the Board, Chief Executive Officer, Secretary | ||
| Fabian Blank, Director | ||
| Bradley Radoff, Independent Director | ||
| Dieter Schapfel, Chief Medical Director of Enzo Clinical Labs | ||
| Kara Cannon, Corporate Vice President - Commercial Operations |
Enzo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Enzo Biochem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.13 | |||
| Return On Asset | -0.0746 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (0.22) % | |||
| Current Valuation | (5.4 M) | |||
| Shares Outstanding | 52.4 M | |||
| Shares Owned By Insiders | 21.68 % | |||
| Shares Owned By Institutions | 34.78 % | |||
| Number Of Shares Shorted | 364.9 K | |||
| Price To Earning | 26.60 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Enzo Stock
If you are still planning to invest in Enzo Biochem check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzo Biochem's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |